Inhibition of EZH2 degradation as a novel approach to overcome drug resistance in acute myeloid leukemia

由 Göllner, Stefanie, Müller-Tidow, Carsten
發表在 Mol Cell Oncol (2017)

The Indications for Allogeneic Stem Cell Transplantation in Myeloid Malignancies

由 Müller, Lutz P, Müller-Tidow, Carsten
發表在 Dtsch Arztebl Int (2015)

The limited contribution of DNA methylation to PML-RARα induced leukemia

由 Rohde, Christian, Schoofs, Till, Müller-Tidow, Carsten
出版 2013

Improving consolidation therapy in acute myeloid leukemia - a tough nut to crack

由 Schlenk, Richard F., Jaramillo, Sonia, Müller-Tidow, Carsten
發表在 Haematologica (2018)

AMLVaran: a software approach to implement variant analysis of targeted NGS sequencing data in an oncological care setting

由 Wünsch, Christian, Banck, Henrik, Müller-Tidow, Carsten, Dugas, Martin
發表在 BMC Med Genomics (2020)

Comparison of Open-access Databases for Clinical Variant Interpretation in Cancer: A Case Study of MDS/AML

由 BANCK, HENRIK, DUGAS, MARTIN, MÜLLER-TIDOW, CARSTEN, SANDMANN, SARAH
發表在 Cancer Genomics Proteomics (2021)

Workflow to improve patient recruitment for clinical trials within hospital information systems – a case-study

由 Dugas, Martin, Lange, Matthias, Berdel, Wolfgang E, Müller-Tidow, Carsten
出版 2008

Characterization of the Ca(2+)-regulated Ezrin-S100P Interaction and Its Role in Tumor Cell Migration

由 Austermann, Judith, Nazmi, Ali Reza, Müller-Tidow, Carsten, Gerke, Volker
出版 2008

The Treatment of Elderly Patients With Acute Myeloid Leukemia

由 Krug, Utz, Büchner, Thomas, Berdel, Wolfgang E, Müller-Tidow, Carsten
出版 2011

HIS-based Kaplan-Meier plots - a single source approach for documenting and reusing routine survival information

由 Breil, Bernhard, Semjonow, Axel, Müller-Tidow, Carsten, Fritz, Fleur, Dugas, Martin
出版 2011

Value of Different Comorbidity Indices for Predicting Outcome in Patients with Acute Myeloid Leukemia

由 Wass, Maxi, Hitz, Friederike, Schaffrath, Judith, Müller-Tidow, Carsten, Müller, Lutz P.
發表在 PLoS One (2016)

DDX41-related myeloid neoplasia

由 Maciejewski, Jaroslaw P., Padgett, Richard A., Brown, Anna L., Müller-Tidow, Carsten
發表在 Semin Hematol (2017)

Prognostic factors of resected node-positive lung cancer: location, extent of nodal metastases, and multimodal treatment

由 Marra, Alessandro, Richardsen, Gunther, Wagner, Wolfgang, Müller-Tidow, Carsten, Koch, Olaf M., Hillejan, Ludger
出版 2011

Hematological Malignancies in Adults With a Family Predisposition

由 Bochtler, Tilmann, Haag, Georg-Martin, Schott, Sarah, Kloor, Matthias, Krämer, Alwin, Müller-Tidow, Carsten
發表在 Dtsch Arztebl Int (2018)

Efficacy of targeted drugs in germ cell cancer cell lines with differential cisplatin sensitivity

由 Schaffrath, Judith, Schmoll, Hans-Joachim, Voigt, Wieland, Müller, Lutz P., Müller-Tidow, Carsten, Mueller, Thomas
發表在 PLoS One (2017)

Dissecting the role of p53 phosphorylation in homologous recombination provides new clues for gain-of-function mutants

由 Restle, Anja, Färber, Martin, Baumann, Cindy, Böhringer, Michael, Scheidtmann, Karl Heinz, Müller-Tidow, Carsten, Wiesmüller, Lisa
出版 2008

The Inhibitor of Growth Protein 5 (ING5) Depends on INCA1 as a Co-Factor for Its Antiproliferative Effects

由 Zhang, Feng, Bäumer, Nicole, Rode, Miriam, Ji, Ping, Zhang, Tao, Berdel, Wolfgang E., Müller-Tidow, Carsten
出版 2011

A Limited Role for the Cell Cycle Regulator Cyclin A1 in Murine Leukemogenesis

由 Bäumer, Nicole, Bäumer, Sebastian, Haak, Miriam, Koschmieder, Steffen, Schönig, Kai, Berdel, Wolfgang E., Müller-Tidow, Carsten
發表在 PLoS One (2015)

BCR-ABL(+) acute myeloid leukemia: are we always dealing with a high-risk disease?

由 Neuendorff, Nina Rosa, Hemmati, Philipp, Arnold, Renate, Ihlow, Jana, Dörken, Bernd, Müller-Tidow, Carsten, Westermann, Jörg
發表在 Blood Adv (2018)

Interleukin-18 and Hematopoietic Recovery after Allogeneic Stem Cell Transplantation

由 Radujkovic, Aleksandar, Kordelas, Lambros, Bogdanov, Rashit, Müller-Tidow, Carsten, Beelen, Dietrich W., Dreger, Peter, Luft, Thomas
發表在 Cancers (Basel) (2020)